N/A
Manufactured by AAA Pharmaceutical, Inc.
117,087 FDA adverse event reports analyzed
Last updated: 2026-04-14
DIPHENHYDRAMINE HYDROCHLORIDE CAPSULE, LIQUID FILLED is a medication tracked in the FDA Adverse Event Reporting System (FAERS), manufactured by AAA Pharmaceutical, Inc.. The most commonly reported adverse reactions for DIPHENHYDRAMINE HYDROCHLORIDE CAPSULE, LIQUID FILLED include FATIGUE, OFF LABEL USE, PAIN, HEADACHE, DRUG INEFFECTIVE. This page provides a comprehensive breakdown of reported side effects, safety signals, patient demographics, and AI-powered safety analysis for DIPHENHYDRAMINE HYDROCHLORIDE CAPSULE, LIQUID FILLED.
Out of 19,872 classified reports for DIPHENHYDRAMINE HYDROCHLORIDE CAPSULE, LIQUID FILLED:
The FDA classifies an adverse event as “serious” if it results in death, hospitalization, disability, congenital anomaly, or requires intervention to prevent permanent damage.
Demographics reflect voluntary FDA adverse event reporting patterns and may not represent the full patient population.
This profile reflects 117,087 FDA FAERS reports that mention DIPHENHYDRAMINE HYDROCHLORIDE CAPSULE, LIQUID FILLED. Reporting is voluntary and does not prove that the drug caused any listed event.
Frequently reported terms in FAERS include FATIGUE, OFF LABEL USE, PAIN, HEADACHE, DRUG INEFFECTIVE, INFUSION RELATED REACTION. Rankings reflect reporting volume in this dataset, not confirmed side effect rates in the general population.
Labeling and FAERS entries often list AAA Pharmaceutical, Inc. in connection with DIPHENHYDRAMINE HYDROCHLORIDE CAPSULE, LIQUID FILLED. Always verify the specific product and NDC with your pharmacist.